<div class="container">

<table style="width: 100%;"><tr>
<td>illust3</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>Data set of an AIDS clinical trial</h2>

<h3>Description</h3>

<p>Data set from an AIDS clinical trial designed to study the benefits of Zidovudine therapy in patients in the early stage of HIV infection. It contains interval-censored data of 1607 individuals.</p>


<h3>Usage</h3>

<pre><code class="language-R">data(illust3)</code></pre>


<h3>Format</h3>

<p>A data frame with 1607 observations on the following 3 variables.
</p>

<dl>
<dt><code>left</code></dt>
<dd>
<p>Left endpoint of censoring interval.</p>
</dd>
<dt><code>right</code></dt>
<dd>
<p>Right endpoint of censoring interval.</p>
</dd>
<dt><code>group</code></dt>
<dd>
<p>Treatment group (1 = deferred therapy; 2 = 500 mg/day dosage; 3 = 1500 mg/day dosage).</p>
</dd>
</dl>
<h3>References</h3>

<p>Calle, M. L. and Gómez, G. (2001). Nonparametric Bayesian estimation from interval-censored data using Monte Carlo methods. Journal of
Statistical Planning and Inference <b>98</b>, 73–87.
</p>
<p>Gómez, G., Calle, M. L. and Oller, R. (2004). Frequentist and Bayesian approaches for interval-censored data and their implementation in R.
Statistical Papers <b>45</b>, 139–173.
</p>
<p>Volberding, P. A., Lagakos, S. W., Grimes, J. M., Stein, D. S., <em>et al.</em> (1995). A Comparison of Immediate with Deferred Zidovudine
Therapy for Asymptomatic HIV-Infected Adults with CD4 Cell Counts of 500 or More per Cubic Millimeter. The New England Journal of Medicine
<b>333</b>, 401–407.
</p>


</div>